Advertisement


Aakash Desai, MPH, MD, on the Precision Oncology Promise: Can We Deliver?

2021 ASCO Quality Care Symposium

Advertisement

Aakash Desai, MPH, MD, of the Mayo Clinic in Rochester, Minnesota, talks about the urgent need for drug pricing reform, given the average expenditure of Medicare part D, and the ultimate out-of-pocket costs for patients with cancer. The promise of precision oncology will fail, says Dr. Desai, if we fail to bring the right drugs to the right patient at the right time, with the right price.



Related Videos

Lung Cancer
Health-Care Policy
Legislation

Leticia Nogueira, PhD, MPH, on the Association of Medicaid Expansion and Early Mortality Following Lung Cancer Surgery

Leticia Nogueira, PhD, MPH, of the American Cancer Society, discusses results from a study designed to evaluate the impact of Medicaid expansion under the Affordable Care Act (ACA). In Medicaid-expansion states, mortality among patients after lung cancer surgery decreased from 2.4% before the ACA to 0.8% after the ACA, with no significant change in non–Medicaid-expansion states.

Issues in Oncology

John V. Cox, DO, MBA, on Reshaping Practice Models to Better Care for Patients With Cancer

John V. Cox, DO, MBA, of The University of Texas Southwestern Medical Center, summarizes his Joseph V. Simone Lecture, in which he stressed the need for coordinated care among practices. The concept of oncology medical homes, he says, has evolved to a broader-based model in which oncologists cooperate with other practices to manage patients and their comorbidities with optimal outcomes. Professional organizations such as the American College of Physicians and ASCO can provide clinicians with the tools they need to engage in this future of health care.

Issues in Oncology
Supportive Care

Manali I. Patel, MD, MPH, on Community-Based Intervention and Cancer Care Disparity

Manali I. Patel, MD, MPH, of Stanford University School of Medicine, discusses data suggesting that community health workers and innovative payer models can better engage low-income and minority patients with cancer, improve their health-related quality of life, and reduce unwanted and unnecessary acute care.

Issues in Oncology

Morgan R.L. Lichtenstein, MD, on Insurance Plan, Prior Authorization, and Time to Receipt of Oral Anticancer Drugs

Morgan R.L. Lichtenstein, MD, of Columbia University Medical Center, discusses a single-center prospective study examining the complex relationship between time to oral oncolytic receipt and clinical or process-related factors, such as prior authorization, diagnosis, and insurance type.

Issues in Oncology

Sarah S. Mougalian, MD, on a Next-Day Access Program for Patients With Cancer

Sarah S. Mougalian, MD, of Yale Cancer Center, discusses the increasingly common problem of long wait times for access to oncology care. Her team developed a next-day access program in several of Yale’s oncology services, which was well received by patients and decreased the time to first visit.

Advertisement

Advertisement



Advertisement